Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data

por Murthy, Sanjay K., Shukla, Tushar, Antonova, Lilia, Belair, Marc-Andre, Ramsay, Tim, Gallinger, Zane, Nguyen, Geoffrey C., Benchimol, Eric I.
Publicado 2019

SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY

por Quan, Joshua, Ma, Christopher, Panaccione, Remo, Kanji, Jamil, Tipples, Graham, Sharifi, Nastaran, van Huyssteen, Michelle, Markovinovic, Ante, Turnbull, LeeAnn, Bindra, Gurmeet, Mahoney, Douglas, Ingram, Richard, Hracs, Lindsay, Coward, Stephanie, Windsor, Joseph, Buie, Michael, Chan, Melissa, Ferraz, Jose, Lu, Cathy, Mathivanan, Meena, Novak, Kerri, Seow, Cynthia, Shukla, Tushar, Kaplan, Gilaad
Publicado 2022

654: A THIRD DOSE OF SARS-COV-2 VACCINE YIELDS HIGH ANTIBODY LEVELS COMPARED TO TWO DOSE VACCINATION SCHEDULE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

por Quan, Joshua, Ma, Christopher, Panaccione, Remo, Kanji, Jamil, Charlton, Carmen, Tipples, Graham, Sharifi, Nastaran, Herauf, Michelle, Markovinovic, Ante, Turnbull, LeeAnn, Bernatsky, Sasha, Bindra, Gurmeet K., Mahoney, Douglas, Ingram, Richard J., Hracs, Lindsay, Coward, Stephanie, Windsor, Joseph W., Buie, Michael J., Chan, Melissa, Ferraz, Jose G., Lu, Cathy, Mathivanan, Meena, Novak, Kerri L., Seow, Cynthia H., Shukla, Tushar, Kaplan, Gilaad
Publicado 2022

Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY

por Quan, Joshua, Ma, Christopher, Panaccione, Remo, Kanji, Jamil, Charlton, Carmen, Tipples, Graham, Sharifi, Nastaran, Herauf, Michelle, Markovinovic, Ante, Turnbull, LeeAnn, Bernatsky, Sasha, Bindra, Gurmeet K., Mahoney, Douglas, Ingram, Richard J., Hracs, Lindsay, Coward, Stephanie, Windsor, Joseph W., Buie, Michael J., Chan, Melissa, Ferraz, Jose G., Lu, Cathy, Mathivanan, Meena, Novak, Kerri L., Seow, Cynthia H., Shukla, Tushar, Kaplan, Gilaad
Publicado 2022